These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1329357)

  • 1. [Dyslipidemia and an elevated lipid level in the cells in experimental herpetic infection and their correction with antiviral chemotherapeutic agents].
    Amvros'eva TV; Votiakov VI; Andreeva OT; Serebriakova EV; Cheshchevik AB; Samarina MP; Mishaeva NP; Zgirovskaia AA
    Vopr Virusol; 1992; 37(1):61-4. PubMed ID: 1329357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lipid metabolism in experimental virus infections].
    Ambros'eva TV; Votiakov VI; Andreeva OT; Serebriakova EV; Vladyko GV; Samarina MP
    Biull Eksp Biol Med; 1992 Sep; 114(9):302-4. PubMed ID: 1477368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dyslipidemia in herpetic infection].
    Amvros'eva TV; Votiakov VI; Chekina AIu; Andreeva OT; Samarina MP
    Ter Arkh; 1994; 66(11):48-50. PubMed ID: 7900019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis.
    Hajjar DP; Pomerantz KB; Falcone DJ; Weksler BB; Grant AJ
    J Clin Invest; 1987 Nov; 80(5):1317-21. PubMed ID: 3119662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiherpetic activity of xylure].
    Chekunova EV; Marennikova SS; Mel'nik SIa; Preobrazhenskaia MN; Zaguliaeva OA
    Vopr Virusol; 1985; 30(4):444-6. PubMed ID: 3904209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Para-aminobenzoic acid in therapy of experimental keratitis caused by herpes simplex virus in rabbits: the therapeutic effect and decrease of infectious titer].
    Akberova SI; Leont'eva NA; Stroeva OG; Galegov GA
    Vestn Oftalmol; 1996; 112(4):23-6. PubMed ID: 9019907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of T-actemodulin on herpes simplex virus infection.
    Varadinova T; Trashlieva M; Kemileva Z
    Acta Physiol Pharmacol Bulg; 1992; 18(2):33-40. PubMed ID: 1339076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The antiviral activity of peptide immunomodulator "Gepon" in experimental infections caused by herpes simplex viruses types 1 and 2].
    Barinskiĭ IF; Alimbarova LM; Lazarenko AA; Ataullakhanov RI
    Vopr Virusol; 2003; 48(5):30-3. PubMed ID: 14598478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-herpes simplex virus effect of an aqueous extract of propolis.
    Huleihel M; Isanu V
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):923-7. PubMed ID: 12455181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiherpetic chemotherapy].
    Shiraki K; Kurokawa M
    Nihon Rinsho; 2000 Apr; 58(4):939-43. PubMed ID: 10774220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipids of blood and blood vessel wall in rabbits of various age with renal hypertension under conditions of experimental atherosclerosis].
    Chaialo PP; Kozhura IM; Cherkasskiĭ LP; Polinskaia VI
    Vopr Med Khim; 1981; 27(3):320-6. PubMed ID: 7281572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development and practical use of new experimental models of the various forms of herpetic infection].
    Marennikova SS; Matsevich GR; Chekunova EV; Nikulina VG; Rozina EE
    Vopr Virusol; 1986; 31(1):59-65. PubMed ID: 3515764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
    Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
    J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of an antiviral factor obtained from infected chick embryo fibroblasts in an experimental herpetic infection].
    Gribkova NV; Andreeva OT; Votiakov VI; Khmara ME
    Vopr Virusol; 1994; 39(4):182-4. PubMed ID: 7998399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
    Levin MJ; Bacon TH; Leary JJ
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular motions and thermotropic phase behavior of triacylglycerols and cholesteryl esters in herpesvirus-infected arterial smooth muscle cells: a deuterium nuclear magnetic resonance study.
    Hajjar DP; Picart F; Pomerantz KB
    Biophys Chem; 1992 Jul; 43(3):255-63. PubMed ID: 1643239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluatio of the antiviral activity of the antibiotic rubomycin-complex and its components B and C].
    Bliumberg NA; Kalamova NI
    Antibiotiki; 1970 Apr; 15(4):307-11. PubMed ID: 5489277
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental study of the antiviral properties of antibiotic 6734-21].
    Goncharskaia TIa
    Antibiotiki; 1978 Jan; 23(1):58-62. PubMed ID: 203225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Virus-induced morphological changes in arterial vessels of rabbits with herpetic keratoconjunctivitis and in patients with generalized herpetic infection].
    Amvros'eva TV; Nedz'ved' MK; Votiakov VI; Andreeva OT
    Biull Eksp Biol Med; 1996 Jun; 121(6):702-6. PubMed ID: 9035772
    [No Abstract]   [Full Text] [Related]  

  • 20. Marine organisms as a therapeutic source against herpes simplex virus infection.
    Vo TS; Ngo DH; Ta QV; Kim SK
    Eur J Pharm Sci; 2011 Sep; 44(1-2):11-20. PubMed ID: 21782018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.